Ditchcarbon
  • Customers
  1. Organizations
  2. Alfasigma S.p.A.
Public Profile
Pharmaceutical Preparation Manufacturing
IT
updated 15 days ago

Alfasigma S.p.A.

Company website

Alfasigma S.p.A., a prominent player in the pharmaceutical industry, is headquartered in Italy and operates extensively across Europe, North America, and Asia. Founded in 2015 through the merger of Alfa Wassermann and Sigma-Tau, the company has quickly established itself as a leader in the development and marketing of prescription medicines, particularly in the fields of gastroenterology, central nervous system disorders, and cardiovascular health. Alfasigma's core products, including innovative treatments and generics, are distinguished by their commitment to quality and efficacy. The company has achieved significant milestones, such as expanding its global footprint and enhancing its research capabilities. With a strong market position and a focus on patient-centric solutions, Alfasigma continues to make strides in improving health outcomes worldwide.

DitchCarbon Score

How does Alfasigma S.p.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Alfasigma S.p.A.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

33%

Let us know if this data was useful to you

Alfasigma S.p.A.'s reported carbon emissions

Alfasigma S.p.A., headquartered in Italy, currently does not report any specific carbon emissions data, as there are no available figures for their emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As of now, Alfasigma's climate commitments and reduction initiatives remain unspecified, indicating a potential area for development in their sustainability strategy. Without emissions data or reduction targets, it is challenging to assess their environmental impact or progress towards climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Alfasigma S.p.A.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Alfasigma S.p.A. is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Alfasigma S.p.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 23 hours ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Fresenius

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250918.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy